Latest NewsOct 30, 2025HiFiBiO Therapeutics Announces the Appointment of Leading I&I Experts to its Scientific Advisory BoardAll Filter By: Year20252024202320222021202020192018201720162015Aug 17, 2020HiFiBiO Therapeutics Collaborates with Coronavirus Immunotherapy Consortium in the Fight Against COVID-19Jul 3, 2020HFB9-2, a novel Galectin-9 neutralizing antibody to reverse immune suppression in the tumor microenvironmentJul 3, 2020Discovery and characterization of novel TNFR2 antibodies to modulate T cell activities in immunosuppressive environmentJul 3, 2020HFB301001, a novel OX40 agonistic antibody with a unique pharmacological profile and innovative biomarker strategyJun 22, 2020HiFiBiO Therapeutics Presents Three Novel Immuno-Oncology Programs at 2020 AACR Virtual Annual Meeting II< 1 … 10 11 12 13 14 … 18 >
